AUGMENTED INTELLIGENCE IN DRUG DISCOVERY XCHANGE
EAST COAST 2023
Boston
May 25, 2023

Welcome to hubXchange’s Augmented Intelligence (AI) in Drug Discovery Xchange East Coast 2023, bringing together executives from pharma and biotech to address and find solutions to the key issues faced in AI-led drug discovery.

Discussion topics will cover Data Quality, Target Identification, Lead Generation, Lead Optimization and Drug Response Prediction.

Take advantage of this unique highly interactive meeting format designed for maximum engagement, collaboration and networking with your peers.

Please note this is an In-Person meeting.

VENUE DETAILS: Hilton Boston Woburn Hotel, 2 Forbes Road, Woburn MA 01801

SNAPSHOTS OF DISCUSSION TOPICS

  • Overcoming current limitations in data generation and management
  • Guidance on standard practice in clinical genomic data generation and data analysis pipelines
  • Use of AI in integrating multi-dimensional datasets for target discovery
  • Using AI to make a complex drug discovery process smarter
  • Molecular design cycle: computation-first approach
  • Challenges and approaches to building deep learning models for antibody lead optimization

  • Can machine learning methods provide insights and predictions for cancer drug response?

Full Xchange Agenda

Click on each track for detailed agenda

Data Quality

Time
Titles and Bullets
Facilitator
8:00 – 8:30
Registration
8:30 – 9:00

Opening Address & Keynote Presentation

9:05 – 10:05

Addressing the challenge of integration of omics data [Topic TBC]

 

Group Lead Pharma Discovery, Abbvie

10:10 – 10:40
1-2-1 Meetings / Networking Break
10:40 – 11:10
1-2-1 Meetings / Networking Break
11:10 – 11:20
Morning Refreshments
11:20 – 12:20

Sponsor-led Roundtable

12:20 – 13:20

Networking Lunch

13:55 – 14:25

1-2-1 Meetings / Networking Break

14:25 – 14:55

1-2-1 Meetings / Networking Break

15:35 – 16:35

Guidance on standard practice in clinical genomic data generation and data analysis pipelines

  • Vendor Qualification and fit for purpose assay selection
  • Global regulatory guidance for CRO based data generation 
  • Integration of new technologies in clinical research

`

 

Senior Scientist, Takeda

16:35 – 16:45

Afternoon Refreshments

16:45 – 17:45

Data quality, variability and integrity: how do we achieve it? [Topic TBC]

Director of Computational Biology, Immunitas Therapeutics

17:45 – 18:45
Evening Drinks Reception

Partner

Augmented Intelligence in Drug Discovery Xchange | East Coast 2023
Register